Hereditary early-onset Parkinson's disease caused by mutations in PINK1
- PMID: 15087508
- DOI: 10.1126/science.1096284
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra. We previously mapped a locus for a rare familial form of PD to chromosome 1p36 (PARK6). Here we show that mutations in PINK1 (PTEN-induced kinase 1) are associated with PARK6. We have identified two homozygous mutations affecting the PINK1 kinase domain in three consanguineous PARK6 families: a truncating nonsense mutation and a missense mutation at a highly conserved amino acid. Cell culture studies suggest that PINK1 is mitochondrially located and may exert a protective effect on the cell that is abrogated by the mutations, resulting in increased susceptibility to cellular stress. These data provide a direct molecular link between mitochondria and the pathogenesis of PD.
Comment in
-
Biomedicine. Parkinson's--divergent causes, convergent mechanisms.Science. 2004 May 21;304(5674):1120-2. doi: 10.1126/science.1098966. Science. 2004. PMID: 15155938 No abstract available.
Similar articles
-
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.Neurobiol Dis. 2007 Feb;25(2):401-11. doi: 10.1016/j.nbd.2006.10.007. Epub 2006 Nov 30. Neurobiol Dis. 2007. PMID: 17141510
-
Parkin stabilizes PINK1 through direct interaction.Biochem Biophys Res Commun. 2009 Jun 5;383(3):331-5. doi: 10.1016/j.bbrc.2009.04.006. Epub 2009 Apr 7. Biochem Biophys Res Commun. 2009. PMID: 19358826
-
Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson's Disease.Cells. 2021 Nov 4;10(11):3022. doi: 10.3390/cells10113022. Cells. 2021. PMID: 34831247 Free PMC article. Review.
-
Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.J Neurochem. 2015 Jun;133(5):750-65. doi: 10.1111/jnc.13039. Epub 2015 Mar 1. J Neurochem. 2015. PMID: 25626353
-
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18. Exp Neurol. 2009. PMID: 19303005 Review.
Cited by
-
Blood-brain barrier alterations and their impact on Parkinson's disease pathogenesis and therapy.Transl Neurodegener. 2024 Jul 29;13(1):37. doi: 10.1186/s40035-024-00430-z. Transl Neurodegener. 2024. PMID: 39075566 Free PMC article. Review.
-
PINK1 knockout rats show premotor cognitive deficits measured through a complex maze.Front Neurosci. 2024 May 16;18:1390215. doi: 10.3389/fnins.2024.1390215. eCollection 2024. Front Neurosci. 2024. PMID: 38817910 Free PMC article.
-
Mitochondrial quality control in human health and disease.Mil Med Res. 2024 May 29;11(1):32. doi: 10.1186/s40779-024-00536-5. Mil Med Res. 2024. PMID: 38812059 Free PMC article. Review.
-
PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants.Cell Mol Life Sci. 2024 May 20;81(1):223. doi: 10.1007/s00018-024-05262-8. Cell Mol Life Sci. 2024. PMID: 38767677 Free PMC article. Review.
-
Pharmacological PINK1 activation ameliorates Pathology in Parkinson's Disease models.Res Sq [Preprint]. 2024 May 10:rs.3.rs-4356493. doi: 10.21203/rs.3.rs-4356493/v1. Res Sq. 2024. PMID: 38765977 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials